Compare DexCom, Inc. (DXCM) vs Harmony Gold Mining Co. (HMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Harmony Gold Mining Co. — how do they compare? DexCom, Inc. trades at $78.66 (market cap $28.06B), while Harmony Gold Mining Co. trades at $14.87 (market cap $9.38B). The key difference: DexCom, Inc. is far larger — about 3× Harmony Gold Mining Co.'s market cap, and Harmony Gold Mining Co. pays a 2.69% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | HMY | |
|---|---|---|
Market Cap | $28.06B | $9.38B |
Sector | Health | Basic Materials |
52-Week High | $89.53 | $26.04 |
52-Week Low | $54.84 | $12.61 |
Enterprise Value | $27.03B | $9.72B |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Harmony Gold Mining (HMY) trades at $15.24, up 1.67% today, with bearish technical signals from moving averages. The company shows strong fundamentals with 2024 revenue of $61.38B and net income of $8.59B, delivering a 20.06% net margin. Recent earnings show mixed results with a Q4 2025 miss but previous quarters beating expectations. The stock offers a dividend yield with a $0.31 payment scheduled for May 2026.
HMY presents value with attractive valuation ratios (P/E 9.69, EV/EBITDA 5.04) and robust profitability (ROE 32.32%). However, analyst sentiment is cautious with 70% hold ratings, and technical indicators suggest near-term pressure. Key risks include gold price volatility and Federal Reserve policy impacts, while the transition to gold-copper hybrid operations offers long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Harmony Gold Mining Co.
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →
